Martin Prlic

Title: Martin Prlic: Innovator in Immunology

Introduction

Martin Prlic is a notable inventor based in Seattle, WA, who has made significant contributions to the field of immunology. He holds 2 patents that focus on innovative systems and methods for modulating immune responses. His work is particularly relevant in the context of therapeutic strategies for inflammatory conditions.

Latest Patents

Prlic's latest patents include "Systems and methods for immunomodulation of mucosal-associated invariant T cells." This patent describes systems and methods to modulate the function of mucosal-associated invariant T (MAIT) cells in the absence of a T cell receptor (TCR) signal. These innovations can be utilized to elucidate the function of MAIT cells and assess potential therapeutic strategies for conditions associated with inflammation. Another significant patent is "NKG2D decoys," which details single chain, multimerized, and/or glycosylated NKG2D decoys. These decoys exhibit high affinity and avidity for surface-bound and soluble NKG2D ligands, with applications in identifying NKG2D ligands, treating cancer, graft vs. host disease (GVHD), and inflammatory conditions, as well as enhancing immune responses against vaccines.

Career Highlights

Martin Prlic is affiliated with the Fred Hutchinson Cancer Center, where he continues to advance his research in immunology. His work is instrumental in developing new therapeutic approaches that could significantly impact patient care.

Collaborations

Prlic collaborates with talented colleagues, including Julia Berkson and Chloe Slichter, who contribute to his research endeavors.

Conclusion

Martin Prlic is a distinguished inventor whose work in immunology is paving the way for innovative therapeutic strategies. His patents reflect a commitment to advancing medical science and improving health outcomes.